New Antidepressants: What Are They and More I Psych Central
2023年7月26日 · New antidepressants, like esketamine and brexanolone, have a fresh approach to treating depression and offer options when other medications may not work. Serotonin reuptake inhibitors...
Beyond SSRIs: How the Newest Antidepressants Work - Healthline
2022年9月5日 · In 2019, the Food and Drug Administration (FDA) approved two new antidepressants, brexanolone and esketamine. There’s also been renewed interest in agomelatine, an antidepressant not...
FDA Approves Auvelity, Faster-Acting Antidepressant
2022年10月11日 · The FDA has approved Auvelity, a new antidepressant that may treat symptoms faster than other medications. The drug may be especially effective for individuals with treatment-resistant depression. Auvelity joins ketamine as a potential new wave of faster-acting antidepressants.
New Antidepressant Exxua (Geriprone) Is Coming in 2024 ...
2024年3月4日 · Exxua represents a promising new antidepressant for Major Depressive Disorder (MDD) with a unique mechanism of action targeting the glutamatergic system. The drug gained FDA approval after years of research involving more than 5,000 patients.
Advances in Treatment for Major Depressive Disorder - WebMD
2023年12月4日 · Treatment for depression isn't just about all the old antidepressants you've already heard of. The new generation of drugs may work faster, and nondrug treatments also are effective.
New Treatment for Clinical Depression Auvelity Approved by FDA
2022年8月23日 · The U.S. Food and Drug Administration on August 19 approved dextromethorphan-bupropion, or Auvelity, a drug used to treat major depressive disorder, also known as clinical depression, in...
FDA Approves First Fast-Acting Drug for Clinical Depression
2022年8月25日 · Clinical trials have found the drug to be safe and quickly effective in helping patients experiencing depression. A new medication called Auvelity was just FDA-approved to treat major...